SEC Form 4 · accession 0001437749-17-007789

BIOLARGO, INC. · BLGO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President · Director

Period of report

Apr 30, 2017

Accepted (ET)

May 2, 2017 · 8:34 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000880242

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2,F3	Apr 30, 2017	M	2,501,937	$0.18	A	7,007,528	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option to Purchase Common Stock^{F5,F8,F7,F4,F6}	$0.18	Apr 30, 2017	F	3,866,630	D	Apr 30, 2007	Apr 30, 2017	Common Stock	2,501,937	1,151,974	D

F2These shares were acquired by the Reporting Person through the exercise of a stock option agreement dated April 30, 2007.
F3Includes 1,528,695 shares beneficially owned indirectly by Reporting Person through ownership of New Millennium Capital Partners LLC; includes 385,000 shares beneficially owned indirectly by Reporting person as trustee for an irrevocable special needs trust for his daughter.
F4The April 30, 2007 option agreement vested in 1/3 increments over a period of three years, and was fully vested and fully exercisable as of April 30, 2010.
F5Reporting Person exercised 3,866,630 shares of the April 30, 2007 stock option allowing for the purchase of 7,733,259 shares. The unexercised portion of the option expired April 30, 2017.
F6The number of shares issued upon exercise was calculated pursuant to a cashless exercise formula, based on the exercise price of $0.18, and the market value of the Issuer's common stock on date of exercise of $0.51 per share.
F7Includes an option to purchase 691,974 shares beneficially owned indirectly by Reporting Person through ownership of New Millennium Capital Partners LLC.
F8Pursuant to the Form 4 General Instructions, number 4(c)(iii), this item is left blank on the exercise of a derivative security.